Skip to main content
TL

TimeWarp Labs

TimeWarp Labs offers the TimeWarp Longevity Protocol 01, a daily regimen of six coordinated capsules plus a monthly cleanse that targets multiple aging pathways in a sequenced format. The protocol uses a research‑backed screening process of 240 longevity compounds and provides evidence dossiers for each ingredient, delivered through an application‑based enrollment system for health‑focused adults seeking a pre‑curated supplement solution.

Park City, United States2200+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Individuals seeking to extend their healthspan often have to combine multiple supplements, each targeting a different aging pathway, which can be confusing, time‑consuming, and may lead to suboptimal dosing or interactions.

Solution

TimeWarp Labs delivers a serialized daily regimen called the TimeWarp Longevity Protocol 01, which bundles six capsules per day plus a monthly cleanse into a single, coordinated system. The protocol is built on a research framework that screens longevity compounds, evaluates their biological interactions, and compiles evidence dossiers to support multi‑pathway targeting. By sequencing the doses, the system aims to act across the full biology of aging without requiring users to assemble separate supplement stacks. The regimen is offered through an application‑based admission process, ensuring participants are matched to the protocol and can receive updates as the product launches in summer 2026.

Target Audience

Primary customers are health‑conscious adults who prioritize longevity, cognitive performance, physical resilience, and disease prevention, and who prefer a pre‑curated supplement system over assembling individual stacks.

Features

  • Six daily capsules formulated to address multiple aging pathways in a coordinated sequence
  • Monthly cleanse supplement designed to complement the daily regimen
  • Compounds selected through systematic screening of 240 longevity agents and evaluation of biological interactions
  • Evidence dossiers and literature reviews compiled for each ingredient to support efficacy claims
  • Application‑based access model with review and admission process to manage participant enrollment
This profile is AI-generated and may contain inaccuracies.